Bionovate Technologies (BIIO) Financial Statements
Bionovate Technologies Financial Overview
Bionovate Technologies's market cap is currently $775. The company's EPS TTM is $-0.01; its P/E ratio is -0.04; Bionovate Technologies has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 21 | Jun 20 | Jun 19 | Jun 18 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -45.37K | $ -33.05K | $ -56.54K | $ -118.88K |
| EBITDA | $ -240.00 | $ -5.70K | $ 43.93K | $ -67.75K |
| Net Income | $ -106.54K | $ -122.05K | $ -208.90K | $ -1.74M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Total Assets | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Total Debt | $ 237.38K | $ 185.38K | $ 183.67K | $ 269.18K |
| Net Debt | $ 237.38K | $ 185.38K | $ 183.67K | $ 269.18K |
| Total Liabilities | $ 503.21K | $ 396.67K | $ 332.29K | $ 309.68K |
| Stockholders' Equity | $ -503.21K | $ -396.67K | $ -332.29K | $ -309.68K |
| Cash Flow | ||||
| Free Cash Flow | $ -236.00 | $ 102.00 | $ -292.00 | $ -1.50M |
| Operating Cash Flow | $ -236.00 | $ 102.00 | $ -292.00 | $ -1.50M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 30.42K | $ 0.00 | $ 11.40K |
Currency in USD
